ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 094,97
-0,09%
Dow Jones
39 069,59
0,01%
DAX
18 693,37
0,04%
Brent Oil
81,965
0,00%
Bitcoin
68 777,12
-0,71%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Kiniksa Pharmaceuticals Ltd (KNSA)

  7. Kiniksa Pharmaceuticals Ltd (KNSA) Actualités

KNSA Kiniksa Pharmaceuticals Ltd

19,05
-0,12 (-0,63%)
25 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Kiniksa Pharmaceuticals Ltd KNSA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,12 -0,63% 19,05 06:00:14
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
19,29 19,03 19,52 19,05 19,17
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
07/5/202422:01GLOBEKiniksa Pharmaceuticals to Present at Bank of America..
23/4/202413:30GLOBEKiniksa Pharmaceuticals Reports First Quarter 2024 Financial..
16/4/202422:01GLOBEKiniksa Pharmaceuticals to Report First Quarter 2024..
02/4/202413:30GLOBEKiniksa Pharmaceuticals Announces Development Indication for..
05/3/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:29EDGAR2Form 144 - Report of proposed sale of securities
29/2/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202413:35EDGAR2Form 8-K - Current report
28/2/202413:30GLOBEKiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year..
27/2/202423:06EDGAR2Form 144 - Report of proposed sale of securities
21/2/202422:01GLOBEKiniksa Pharmaceuticals to Report Fourth Quarter and..
14/2/202422:39EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202421:46EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
04/1/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202413:37EDGAR2Form 8-K - Current report
04/1/202413:30GLOBEKiniksa Pharmaceuticals Provides Corporate Update
03/1/202422:55EDGAR2Form 144 - Report of proposed sale of securities
02/1/202422:01GLOBEKiniksa Pharmaceuticals to Present at 42nd Annual J.P...
11/12/202322:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202322:46EDGAR2Form 144 - Report of proposed sale of securities
02/11/202321:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202312:35EDGAR2Form 8-K - Current report
31/10/202312:30GLOBEKiniksa Pharmaceuticals Reports Third Quarter 2023 Financial..
24/10/202322:01GLOBEKiniksa Pharmaceuticals to Report Third Quarter 2023..
07/9/202301:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202301:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202301:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202301:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202323:26EDGAR2Form 144 - Report of proposed sale of securities
18/8/202322:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
10/8/202322:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
01/8/202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
27/7/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/7/202323:14EDGAR2Form 144 - Report of proposed sale of securities
25/7/202313:40EDGAR2Form 8-K - Current report
25/7/202313:30GLOBEKiniksa Pharmaceuticals Reports Second Quarter 2023..
17/7/202314:00GLOBEKiniksa Pharmaceuticals to Report Second Quarter 2023..
06/6/202322:01GLOBEKiniksa Pharmaceuticals to Present at Goldman Sachs 44th..

Dernières Valeurs Consultées

NASDAQ
KNSA
Kiniksa Pharmaceuticals
LATK
TALUSDT
TalentIDO
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés